| Starkville Urgent Care Clinic | |
|
1201 Stark Road Starkville MS 39760 | |
| (662) 324-9760 | |
| (662) 324-9761 |
| Full Name | Starkville Urgent Care Clinic |
|---|---|
| Speciality | Family Medicine |
| Location | 1201 Stark Road, Starkville, Mississippi |
| Authorized Official Name and Position | Mary Beth Hillman (CEO) |
| Authorized Official Contact | 6623249760 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Starkville Urgent Care Clinic Po Box 845 1201 Stark Road Starkville MS 39760-0845 Ph: (662) 324-9760 | Starkville Urgent Care Clinic 1201 Stark Road Starkville MS 39760 Ph: (662) 324-9760 |
| NPI Number | 1417280884 |
|---|---|
| Provider Enumeration Date | 09/16/2009 |
| Last Update Date | 03/04/2015 |
| Medicare PECOS PAC ID | 8820283310 |
|---|---|
| Medicare Enrollment ID | O20101110000276 |
News Archive
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new technique for fighting deadly and hard-to-treat pancreatic cancer that uses two different types of nanoparticles, the first type clearing a path into tumor cells for the second, which delivers chemotherapy drugs.
Gliomas with mutations in what are called the isocitrate dehydrogenase (IDH) genes are the most common brain tumors diagnosed in younger adults aged 18 to 45 years.
A debilitating side effect of a widely used but harshly potent treatment for colon cancer could be eliminated if a promising new laboratory discovery bears fruit.
Johnson & Johnson provided additional information today on its amended agreement with Merck regarding distribution rights for REMICADE (infliximab) and SIMPONI (golimumab) in markets outside the United States. The amended agreement announced today in a separate news release from both companies concludes a pending arbitration, which had been filed by Johnson & Johnson in May 2009.
Results from a recent study show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417280884 | NPI | - | NPPES |
| 05731806 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 06420 (Mississippi) | Primary |
| Provider Name | Joseph C Hillman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1043433931 PECOS PAC ID: 6204726276 Enrollment ID: I20040317000200 |
News Archive
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new technique for fighting deadly and hard-to-treat pancreatic cancer that uses two different types of nanoparticles, the first type clearing a path into tumor cells for the second, which delivers chemotherapy drugs.
Gliomas with mutations in what are called the isocitrate dehydrogenase (IDH) genes are the most common brain tumors diagnosed in younger adults aged 18 to 45 years.
A debilitating side effect of a widely used but harshly potent treatment for colon cancer could be eliminated if a promising new laboratory discovery bears fruit.
Johnson & Johnson provided additional information today on its amended agreement with Merck regarding distribution rights for REMICADE (infliximab) and SIMPONI (golimumab) in markets outside the United States. The amended agreement announced today in a separate news release from both companies concludes a pending arbitration, which had been filed by Johnson & Johnson in May 2009.
Results from a recent study show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys.
› Verified 9 days ago
News Archive
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new technique for fighting deadly and hard-to-treat pancreatic cancer that uses two different types of nanoparticles, the first type clearing a path into tumor cells for the second, which delivers chemotherapy drugs.
Gliomas with mutations in what are called the isocitrate dehydrogenase (IDH) genes are the most common brain tumors diagnosed in younger adults aged 18 to 45 years.
A debilitating side effect of a widely used but harshly potent treatment for colon cancer could be eliminated if a promising new laboratory discovery bears fruit.
Johnson & Johnson provided additional information today on its amended agreement with Merck regarding distribution rights for REMICADE (infliximab) and SIMPONI (golimumab) in markets outside the United States. The amended agreement announced today in a separate news release from both companies concludes a pending arbitration, which had been filed by Johnson & Johnson in May 2009.
Results from a recent study show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys.
› Verified 9 days ago
Oktibbeha County Hospital Ekg Interpretation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 Hospital Rd, Starkville, MS 39759 Phone: 662-615-2503 Fax: 662-615-2554 | |
The Family Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 501 Hospital Rd, Starkville, MS 39759 Phone: 662-323-3162 Fax: 662-323-1711 | |
Mrh Medical Group, Starkville Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 900 Stark Rd, Starkville, MS 39759 Phone: 662-369-2455 | |
First Priority Healthcare Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1572 Walter Bell Rd, Starkville, MS 39759 Phone: 662-312-2737 | |
Starkville Family Practice Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 100 Brandon Rd, Suite 5, Starkville, MS 39759 Phone: 662-323-1212 | |
Golden Triangle Urgent Care Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 500 Russell St Ste 3, Starkville, MS 39759 Phone: 662-324-2244 Fax: 662-334-2295 | |
Golden Triangle Urgent Care Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 500 Russell St Ste 3, Starkville, MS 39759 Phone: 662-324-2244 Fax: 662-324-2295 |